Malignant Transformation of Grade II Ependymoma in a 2-Year-Old Child: Case Report

 

 Permissions and Reprints

Abstract

Ependymomas are central nervous system neoplasms that account for a third of all posterior fossa tumors in children. The most common location for infratentorial ependymoma is within the fourth ventricle. We present a case report of malignant transformation of an infratentorial grade II ependymoma in a 2-year-old child who presented with vomiting and visual disturbance. An infratentorial brain tumor in the left cerebellar area was totally removed, and the initial pathologic diagnosis was grade II ependymoma. The tumor recurred aggressively 1 year later; subtotal removal and adjuvant chemotherapy were performed. After a second operation, a histopathologic study was performed. The second specimen was defined as a grade III anaplastic ependymoma. Transformation to grade III anaplastic ependymoma is possible for a grade II ependymoma but very rare. The diagnosis of the anaplastic variant of intracranial ependymomas is difficult. Surgical treatment remains the mainstay of the treatment for all cases. Ependymomas in young infants have a worse prognosis than older children, so we need individual clinical evaluation and close follow-up of such cases. This article highlights the requirement of a close follow-up for grade II ependymomas for anaplastic transformation.

• References

• 1 McLaughlin MP, Marcus Jr RB, Buatti JM , et al. Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys 1998; 40 (4) 845-850
  CrossrefPubMedGoogle Scholar
• 2 Schiffer D, Giordana MT. Prognosis of ependymoma. Childs Nerv Syst 1998; 14 (8) 357-361
  CrossrefPubMedGoogle Scholar
• 3 Applegate GL, Marymont MH. Intracranial ependymomas: a review. Cancer Invest 1998; 16 (8) 588-593
  CrossrefPubMedGoogle Scholar
• 4 Lefton DR, Pinto RS, Martin SW. MRI features of intracranial and spinal ependymomas. Pediatr Neurosurg 1998; 28 (2) 97-105
  CrossrefPubMedGoogle Scholar
• 5 Gerszten PC, Pollack IF, Martínez AJ, Lo KH, Janosky J, Albright AL. Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. Pathol Res Pract 1996; 192 (6) 515-522
  CrossrefPubMedGoogle Scholar
• 6 Hamilton RL, Pollack IF. The molecular biology of ependymomas. Brain Pathol 1997; 7 (2) 807-822
  CrossrefPubMedGoogle Scholar
• 7 Merchant TE. Current management of childhood ependymoma. Oncology (Williston Park) 2002; 16 (5) 629-642 , 644; discussion 645–646, 648
  PubMedGoogle Scholar
• 8 Merchant TE, Haida T, Wang MH, Finlay JL, Leibel SA. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997; 86 (6) 943-949
  CrossrefPubMedGoogle Scholar
• 9 Lyons MK, Kelly PJ. Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 1991; 28 (5) 659-664 ; discussion 664–665
  CrossrefPubMedGoogle Scholar
• 10 Palma L, Celli P, Cantore G. Supratentorial ependymomas of the first two decades of life. Long-term follow-up of 20 cases (including two subependymomas). Neurosurgery 1993; 32 (2) 169-175
  CrossrefPubMedGoogle Scholar
• 11 Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Children's Cancer Group study. Med Pediatr Oncol 1996; 27 (1) 8-14
  CrossrefPubMedGoogle Scholar
• 12 Rousseau P, Habrand JL, Sarrazin D , et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 1994; 28 (2) 381-386
  CrossrefPubMedGoogle Scholar
• 13 Perilongo G, Massimino M, Sotti G , et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 1997; 29 (2) 79-85
  CrossrefPubMedGoogle Scholar
• 14 Foreman NK, Love S, Thorne R. Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg 1996; 24 (3) 119-125
  CrossrefPubMedGoogle Scholar
• 15 Horn B, Heideman R, Geyer R , et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 1999; 21 (3) 203-211
  CrossrefPubMedGoogle Scholar
• 16 Sutton LN, Goldwein J, Perilongo G , et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 1990; –1991; 16 (2) 57-65
  CrossrefPubMedGoogle Scholar
• 17 Robertson PL, Zeltzer PM, Boyett JM , et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 1998; 88 (4) 695-703
  CrossrefPubMedGoogle Scholar
• 18 Needle MN, Goldwein JW, Grass J , et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997; 80 (2) 341-347
  CrossrefPubMedGoogle Scholar
• 19 Souweidane MM, Bouffet E, Finlay J. The role of chemotherapy in newly diagnosed ependymoma of childhood. Pediatr Neurosurg 1998; 28 (5) 273-278
  CrossrefPubMedGoogle Scholar
• 20 Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB. Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 1990; 72 (3) 408-417
  CrossrefPubMedGoogle Scholar
• 21 Healey EA, Barnes PD, Kupsky WJ , et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991; 28 (5) 666-671 ; discussion 671–672
  CrossrefPubMedGoogle Scholar
• 22 Mork SJ, Loken AC. Ependymoma: a follow-up study of 101 cases. Cancer 1977; 40 (2) 907-915
  CrossrefPubMedGoogle Scholar
• 23 Pollack IF, Gerszten PC, Martinez AJ , et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995; 37 (4) 655-666 ; discussion 666–667
  CrossrefPubMedGoogle Scholar